Proliferation and osteogenic differentiation of mesenchymal stem cells induced by a short isoform of NELL-1.
Shen Pang,Jia Shen,Yi Liu,Feng Chen,Zhong Zheng,Aaron W James,Ching-Yun Hsu,Hong Zhang,Kevin S Lee,Chunling Wang,Chenshuang Li,Xuepeng Chen,Haichao Jia,Xinli Zhang,Chia Soo,Kang Ting
DOI: https://doi.org/10.1002/stem.1884
IF: 5.845
2015-01-01
Stem Cells
Abstract:Neural epidermal growth factor-like (NEL)-like protein 1 (NELL-1) has been identified as an osteoinductive differentiation factor that promotes mesenchymal stem cell (MSC) osteogenic differentiation. In addition to full-length NELL-1, there are several NELL-1-related transcripts reported. We used rapid amplification of cDNA ends to recover potential cDNA of NELL-1 isoforms. A NELL-1 isoform with the N-terminal 240 amino acid (aa) residues truncated was identified. While full-length NELL-1 that contains 810 aa residues (NELL-1(810)) plays an important role in embryologic skeletal development, the N-terminal-truncated NELL-1 isoform (NELL-1(570)) was expressed postnatally. Similar to NELL-1(810), NELL-1(570) induced MSC osteogenic differentiation. In addition, NELL-1(570) significantly stimulated MSC proliferation in multiple MSC-like populations such as murine C3H10T1/2 MSC cell line, mouse primary MSCs, and perivascular stem cells, which is a type of stem cells proposed as the perivascular origin of MSCs. In contrast, NELL-1(810) demonstrated only limited stimulation of MSC proliferation. Similar to NELL-1(810), NELL-1(570) was found to be secreted from host cells. Both NELL-1(570) expression lentiviral vector and column-purified recombinant protein NELL-1(570) demonstrated almost identical effects in MSC proliferation and osteogenic differentiation, suggesting that NELL-1(570) may function as a pro-osteogenic growth factor. In vivo, NELL-1(570) induced significant calvarial defect regeneration accompanied by increased cell proliferation. Thus, NELL-1(570) has the potential to be used for cell-based or hormone-based therapy of bone regeneration.